Prostatis Group’s iShares Treasury Floating Rate Bond ETF TFLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
22,738
-3,384
-13% -$171K 0.27% 69
2026
Q1
$1.32M Sell
26,122
-4,487
-15% -$227K 0.34% 66
2025
Q4
$1.54M Buy
30,609
+110
+0.4% +$5.55K 0.37% 58
2025
Q3
$1.54M Sell
30,499
-2,732
-8% -$138K 0.39% 57
2025
Q2
$1.68M Buy
33,231
+6,363
+24% +$322K 0.48% 52
2025
Q1
$1.36M Sell
26,868
-663
-2% -$33.5K 0.43% 50
2024
Q4
$1.39M Buy
27,531
+16,766
+156% +$847K 0.41% 59
2024
Q3
$545K Sell
10,765
-10,192
-49% -$515K 0.18% 90
2024
Q2
$1.06M Buy
20,957
+8,345
+66% +$422K 0.37% 62
2024
Q1
$639K Buy
12,612
+4,149
+49% +$210K 0.24% 81
2023
Q4
$415K Sell
8,463
-182,141
-96% -$9.21M 0.17% 92
2023
Q3
$9.67M Buy
+190,604
New +$9.65M 4.73% 5

Other funds holding TFLO

Prostatis Group's TFLO Position: Q2 2026 in Review

Prostatis Group reduced its iShares Treasury Floating Rate Bond ETF (TFLO) stake by 13% in Q2 2026, selling an estimated $171K and leaving 22,738 shares worth $1.15M. The position accounts for 0.27% of the portfolio, ranked #69.

Prostatis Group first reported a position in TFLO in Q3 2023 and has held it in 12 quarters since. The position peaked at $9.67M in Q3 2023. 421 funds tracked by Wall St. Rank hold TFLO as of Q2 2026.

  • Prostatis Group held 22,738 shares of iShares Treasury Floating Rate Bond ETF worth $1.15M as of Q2 2026.
  • Prostatis Group sold 3,384 iShares Treasury Floating Rate Bond ETF shares in Q2 2026, an estimated $171K.
  • iShares Treasury Floating Rate Bond ETF made up 0.27% of Prostatis Group's portfolio in Q2 2026, its #69 holding.
  • Prostatis Group first reported a position in iShares Treasury Floating Rate Bond ETF in Q3 2023 and has held it in 12 quarters since.
  • Prostatis Group's iShares Treasury Floating Rate Bond ETF position peaked at $9.67M in Q3 2023.
  • 421 funds tracked by Wall St. Rank held iShares Treasury Floating Rate Bond ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.